BACS® Patient-Specific Module

K2M Receives FDA Clearance for BACS® Patient-Specific Module

LEESBURG, Va., May 30, 2018 (GLOBE NEWSWIRE) — K2M Group Holdings, Inc. (NASDAQ:KTWO) (the “Company” or “K2M”), a global leader of complex…